|
Real-time Estimate
Cboe BZX
12:36:07 2026-11-13 pm EST
|
5-day change | 1st Jan Change | ||
| 466.18 USD | -0.19% |
|
+1.18% | +42.33% |
| Nov. 12 | Argus Research Adjusts Amgen Price Target to $515 From $460 | MT |
| Nov. 11 | Amgen's Sjogren's drug cuts disease activity in trial | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.19% | +1.18% | +12.85% | +11.49% | +42.33% | +38.65% | +74.69% | +124.62% | +218.17% | 253B | |
| +1.25% | +6.38% | +23.48% | +19.14% | +34.03% | +40.82% | +135.09% | +457.38% | +1,770.20% | 1,271B | |
| +0.95% | +3.52% | +15.02% | +9.10% | +38.17% | +46.45% | +93.69% | +74.87% | +145.23% | 683B | |
| +0.05% | +1.01% | +7.25% | +17.31% | +28.78% | +26.67% | +112.23% | +151.83% | +367.27% | 520B | |
| -0.44% | +3.69% | +12.48% | +11.70% | +23.31% | +39.60% | +69.51% | +9.67% | +73.32% | 389B | |
| -0.27% | -0.30% | +3.04% | +7.92% | +38.98% | +57.42% | +42.76% | +74.80% | +130.27% | 362B | |
| -0.12% | +0.74% | +12.37% | +8.34% | +22.32% | +26.78% | +58.43% | +75.93% | +85.81% | 304B | |
| +0.37% | +0.37% | +17.54% | +19.42% | +1.39% | +3.62% | +36.44% | +55.91% | +220.28% | 286B | |
| +0.33% | +0.87% | +13.81% | +21.87% | +37.16% | +34.46% | +124.67% | +150.51% | +119.34% | 208B | |
| +0.98% | +3.34% | +8.49% | -6.64% | -14.39% | -12.62% | -59.85% | -24.96% | +143.51% | 180B | |
| -0.29% | -2.33% | +1.18% | +7.11% | +15.28% | +11.30% | -0.95% | -42.19% | -11.35% | 164B | |
| -0.68% | -1.53% | +11.02% | +4.31% | +18.83% | +23.98% | +42.17% | +188.30% | +470.55% | 138B | |
| +0.87% | +0.51% | +10.21% | -3.40% | +15.79% | +28.43% | +24.54% | +4.76% | +10.42% | 127B | |
| +1.42% | +2.87% | +13.46% | +27.39% | +33.04% | +28.96% | +131.88% | +391.74% | +659.50% | 124B | |
| -0.43% | +4.61% | +23.83% | +14.61% | +5.90% | -3.14% | +2.71% | -2.74% | +13.50% | 117B | |
| -2.37% | -10.83% | +4.82% | +256.12% | +668.63% | +808.13% | +222.85% | -3.57% | - | 93.61B | |
| +0.55% | +1.14% | +9.04% | +2.96% | +4.77% | +5.58% | +35.84% | -3.67% | -0.54% | 101B | |
| +0.53% | +5.46% | +26.64% | +18.33% | +23.56% | +37.23% | +19.71% | +47.24% | +114.56% | 95.45B | |
| +0.46% | -0.13% | +19.31% | -0.04% | -12.88% | -8.52% | +53.51% | +74.38% | +553.81% | 73.52B | |
| +0.98% | +0.57% | +8.72% | +7.24% | +22.02% | +23.18% | -0.73% | -30.80% | +57.57% | 71.23B | |
| Average | +0.23% | +0.80% | +12.73% | +22.72% | +52.35% | +62.85% | +60.96% | +88.70% | +270.60% | 278B | |
| Weighted average by Cap. | +0.44% | +2.05% | +14.32% | +16.96% | +37.47% | +45.02% | +81.75% | +164.52% | +551.41% |
- Stock Market
- Stocks
- AMGN Stock
- Sector Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
